Get started
Author

Rocco Amendolara

Observed names: AMENDOLARA, ROCCO, Amendolara, Rocco, ROCCO AMENDOLARA
ORCID: 0000-0001-8740-0549
Observed ORCID: 0000-0001-8740-0549
OpenAlex ID: A5068101610
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes
2023 · Ernesto Maddaloni, Lucia Coraggio, et al. · Diabetes/Metabolism Research and Reviews · 24
PDF
Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes
2025 · Renata Risi, Rocco Amendolara, et al. · Cardiovascular Diabetology · 10
PDF
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
2021 · Ernesto Maddaloni, Luca D’Onofrio, et al. · Internal and Emergency Medicine · 10
PDF
Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta‐analysis
2026 · Roberto Franceschi, Enza Mozzillo, et al. · Diabetic Medicine · 9
No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study
2024 · Sara Bodini, Silvia Pieralice, et al. · Clinical Therapeutics · 9
PDF
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study
2024 · Ernesto Maddaloni, Anda M. Naciu, et al. · Diabetes Obesity and Metabolism · 9
PDF
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes
2025 · Rocco Amendolara, Simona Zampetti, et al. · Diabetes Research and Clinical Practice · 8
PDF
Reduced early response to SARS‐CoV2 vaccination in people with type 1 and type 2 diabetes, a 6 months follow‐up study: The CoVaDiab study I
2022 · Luca D’Onofrio, Marta Fogolari, et al. · Diabetes/Metabolism Research and Reviews · 8
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
2024 · Ernesto Maddaloni, Rocco Amendolara, et al. · Expert Opinion on Investigational Drugs · 7
The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
2025 · Silvia Pieralice, Rocco Amendolara, et al. · Diabetes Metabolic Syndrome and Obesity · 4
PDF
Osteocalcin is inversely associated with worse adipose tissue distribution and cardiovascular risk in autoimmune diabetes
2025 · Renata Risi, Rocco Amendolara, et al. · Diabetes Research and Clinical Practice · 3
PDF
IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes
2025 · Rocco Amendolara, Luca D’Onofrio, et al. · The Journal of Clinical Endocrinology & Metabolism · 3
PDF
Distinct Interplay Between β-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes
2026 · Rocco Amendolara, Francesco De Vita, et al. · Diabetes · 2
PDF
Diabetic Neuropathy Is Associated With Lower Bone Mineral Density and Higher Fall Risk in Young Elderly Adults With Type 2 Diabetes
2026 · Luca D'Onofrio, Rocco Amendolara, et al. · Diabetes/Metabolism Research and Reviews · 2
PDF
Liver disease in people with latent autoimmune diabetes in adults (LADA): A cross-sectional study using magnetic resonance elastography
2025 · Ernesto Maddaloni, Marta Zerunian, et al. · Diabetes Research and Clinical Practice · 2
PDF
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
2023 · Luca D’Onofrio, Rocco Amendolara, et al. · International Journal of Molecular Sciences · 2
PDF
Screening Programs for Type 1 Diabetes in Youth: Evidence for Clinical Practice
2026 · Roberto Franceschi, Enza Mozzillo, et al. · PEDIATRICS · 1
The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
2026 · Renata Risi, Domiziana Pauletto, et al. · Diabetes Obesity and Metabolism · 1
Preventing Hospital-Associated Disability: Effects of the Hospital Early Structured Mobilization (HESM) Program on Function and Survival in Older Adults
2026 · Fabrizio Turrini, Giovanni Esposito, et al. · Research Square
Response to Comment on Amendolara et al. Distinct Interplay Between β-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes
2026 · Rocco Amendolara, Francesco De Vita, et al. · Diabetes
PDF
Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot study
2026 · Andrea Carafa, Rosario Luigi Sessa, et al. · Acta Diabetologica
PDF
PB2799 Platelet MRP4 Expression in Aspirin-Treated T1DM Patients Is Associated With Higher Aspirin Efficacy Compared with T2DM
2026 · Simone De Corci, Eleonora Schiera, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes
2026 · Ernesto Maddaloni, Samantha Pezzica, et al. · Diabetologia
PDF
Distinct interplay between β-cell function and insulin resistance in latent autoimmune diabetes in adults versus type 2 diabetes
2026 · Rocco Amendolara, Francesco De Vita, et al.
Distinct interplay between β-cell function and insulin resistance in latent autoimmune diabetes in adults versus type 2 diabetes
2026 · Rocco Amendolara, Francesco De Vita, et al.
Works count: 35
Citation count: 113
H-index: 8
I10-index: 3
Year
Topic
Type